US0383361039
© BusinessWire
22.01.2026
ATR
LISTED
NYSE
Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is February 25, 2026, to stockholders of record as of February 4, 2026.
As previously announced, Aptar will hold...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
ATR
LISTED
NYSE
Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, has been recognized for its leadership on climate change topics by the global environmental non-profit CDP, securing a place on its prestigious “A List” for the second consecutive year.
This press release features mu...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
ATR
LISTED
NYSE
Aptar Announces 2026 Quarterly Conference Call Dates
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.
Quarterly Conference Calls
Press Rel...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
06.01.2026
ATR
LISTED
NYSE
Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura Ring
News Preview
Aptar Digital Health, part of AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced a partnership with ŌURA to integrate Aptar’s Migraine Buddy® with Oura Ring. Migraine Buddy, a leading migraine tracking app with millions of users, will connect with the continuous...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© BusinessWire
05.01.2026
ATR
LISTED
NYSE
Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
News Preview
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced its participation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026.
Stephan Tanda, President and CEO, will present at 11:15 a.m. Eastern Standard Time. Vanessa Kanu,...
Themefolio
Profiler
Peergroup
© BusinessWire
17.12.2025
ATR
LISTED
NYSE
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
News Preview
Aptar Group, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that its Bidose (BDS) Liquid Nasal Spray System is the mechanism for delivering the newly approved CARDAMYST™ (etripamil) Nasal Spray. CARDAMYST received approval by the U.S. Food and Drug Administration (FDA)...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
ATR
LISTED
NYSE
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of America’s Most Responsible Companies 2026 by Newsweek for the seventh consecutive year. Aptar is ranked number 56 out of 600 U.S. companies.
This press release features mu...
Themefolio
Profiler
Peergroup
© BusinessWire
11.11.2025
ATR
LISTED
NYSE
Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today announced its participation at the Jefferies Global Healthcare Conference on Wednesday, November 19, 2025.
Stephan Tanda, President and CEO, will present at 7:00 a.m. Eastern Standard Time. Vanessa Kanu, Execu...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ATR
LISTED
NYSE
Aptar Reports Third Quarter 2025 Results
News Preview
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today reported the following third quarter results for the period ended September 30, 2025, as compared to the corresponding period of the last fiscal year.
This press release features multimedia. View the full releas...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ATR
LISTED
NYSE
Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers
News Preview
Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S Food and Drug Administration (FDA) has granted 510(k) clearance for HeroTracker® Sense as a Class II medical device. This milestone recognizes HeroTracker® Sense - a Bluetooth-enabled sensor - as an innovative connected...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ATR
LISTED
NYSE
Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named a World’s Top Companies for Women 2025 by Forbes for the fifth consecutive year (formerly World’s Top Female Friendly Companies). Aptar is ranked 72 out of the 400 companies included on t...
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
ATR
LISTED
NYSE
Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength
News Preview
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.48 per share, an almost 7% increase from the previous dividend amount, bringing the new annualized dividend to $1.92 per share. The payment date is November 13, 2025, to stoc...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
04.09.2025
ATR
LISTED
NYSE
Aptar Announces 2025 Investor Day
News Preview
AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, will host an Investor Day on Tuesday, September 9, 2025. The event will begin at 9:00 a.m. EDT.
Presentations by members of executive management followed by a moderated Q&A session are expected to conclude at approximatel...
Themefolio
Profiler
Peergroup
© BusinessWire
31.07.2025
ATR
LISTED
NYSE
Aptar Reports Second Quarter 2025 Results
News Preview
AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following second quarter results for the period ended June 30, 2025, as compared to the corresponding period of the last fiscal year.
This press release features multimedia. View the full release here: https...
Themefolio
Profiler
Peergroup
© BusinessWire
10.07.2025
ATR
LISTED
NYSE
Aptar Declares Quarterly Dividend
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is August 14, 2025 to stockholders of record as of July 24, 2025.
As previously announced, Aptar will hold a conference call on Friday, August 1,...
Themefolio
Profiler
Peergroup
© BusinessWire
25.06.2025
ATR
LISTED
NYSE
Aptar Named One of the World’s Most Sustainable Companies by TIME for Second Consecutive Year
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of the World’s Most Sustainable Companies 2025 by TIME. Aptar is ranked 244 out of 500 global companies evaluated by TIME and its partner Statista.
This press release features multim...
Themefolio
Profiler
Peergroup
© BusinessWire
02.06.2025
ATR
LISTED
NYSE
Aptar to Participate in Upcoming Investor Conferences
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it will present at two upcoming investor conferences:
The William Blair 45th Annual Growth Stock Conference in Chicago, IL on Tuesday, June 3, 2025. Stephan Tanda, President and CEO, and Vanessa Kanu, E...
Themefolio
Profiler
Peergroup
© BusinessWire
29.05.2025
ATR
LISTED
NYSE
Aptar Releases 2024 Corporate Sustainability Report
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today released its 2024 Corporate Sustainability Report entitled Progress Takes Shape. Aptar’s report highlights key milestones of its global sustainability strategy across the company’s global operations focused on three key...
Themefolio
Profiler
Peergroup
© BusinessWire
01.05.2025
ATR
LISTED
NYSE
Aptar Reports First Quarter 2025 Results
News Preview
AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following first quarter results for the period ended March 31, 2025, as compared to the corresponding period of the last fiscal year.
This press release features multimedia. View the full release here: https:...
Themefolio
Profiler
Peergroup
© BusinessWire
17.04.2025
ATR
LISTED
NYSE
Aptar Declares Quarterly Dividend
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is May 22, 2025, to stockholders of record as of May 1, 2025.
As previously announced, Aptar will hold a conference call on Friday, May 2, 2025 at...
Themefolio
Profiler
Peergroup
© BusinessWire
16.04.2025
ATR
LISTED
NYSE
Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announces the commencement of a clinical study to validate its proprietary SmartTrack™ platform. The platform was developed by Aptar’s drug services company, Nanopharm. If validated, SmartTrack™ aims to reduce the need f...
Themefolio
Profiler
Peergroup
© BusinessWire
15.04.2025
ATR
LISTED
NYSE
Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has achieved the Platinum level rating in recognition of its sustainability efforts from EcoVadis for the fifth consecutive year. The Platinum rating places Aptar among the top 1% of the more than 150,000 companies rated by Ec...
Themefolio
Profiler
Peergroup
© BusinessWire
27.03.2025
ATR
LISTED
NYSE
Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been named one of Barron’s 100 Most Sustainable U.S. Companies for the seventh consecutive year and is ranked number 26 out of the top 100 companies for 2025.
This press release features multimedia. View the full release h...
Themefolio
Profiler
Peergroup
© BusinessWire
20.03.2025
ATR
LISTED
NYSE
Aptar Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been recognized for its leadership on climate change topics by the global environmental non-profit CDP, securing a place on its prestigious “A List.”
This press release features multimedia. View the full release here: http...
Themefolio
Profiler
Peergroup
© BusinessWire
06.02.2025
ATR
LISTED
NYSE
Aptar Reports Fourth Quarter and Annual 2024 Results
News Preview
AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth quarter results due to solid operational performance driven by top and bottom line improvements. Results were driven by sales growth in pharma solutions, increased demand for closures technologies a...
Themefolio
Profiler
Peergroup
© BusinessWire
23.01.2025
ATR
LISTED
NYSE
Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.45 per share. The payment date is February 26, 2025, to stockholders of record as of February 5, 2025.
As previously announced, Aptar will hold a confer...
Themefolio
Profiler
Peergroup
© BusinessWire
14.01.2025
ATR
LISTED
NYSE
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Sixth Consecutive Year
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of America’s Most Responsible Companies 2025 by Newsweek for the sixth consecutive year. Aptar is ranked number 71 out of 600 U.S. companies.
This press release features multimedia....
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2025
ATR
LISTED
NYSE
Aptar Announces 2025 Quarterly Conference Call Dates
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.
Quarterly Conference Calls
Press Release (1...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2025
ATR
LISTED
NYSE
Aptar to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced their participation at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025.
Stephan Tanda, President and CEO, will present at 12:45 p.m. Eastern Standard Time. Vanessa Kanu, Execut...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2024
ATR
LISTED
NYSE
Aptar Named Among Top 50 of the ‘World’s Top Companies for Women 2024’ by Forbes
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named a World’s Top Companies for Women 2024 by Forbes for the fourth consecutive year (formerly World’s Top Female Friendly Companies). Aptar is ranked 41 out of the 400 companies included on...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2024
ATR
LISTED
NYSE
Aptar Reports Third Quarter 2024 Results
News Preview
AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong third quarter results due to solid operational performance and margin improvement across the company. Results were driven by growth in proprietary drug delivery systems, as well as increased demand for clo...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2024
ATR
LISTED
NYSE
Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, announced that it was awarded a contract from the U.S. Federal Government to advance development of its ActivShield™ technology. This innovative solution sterilizes medical devices and instruments without the need for a power...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2024
ATR
LISTED
NYSE
Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend
News Preview
The Board of Directors of AptarGroup, Inc. (NYSE: ATR) authorized the repurchase of up to $500 million of the Company’s common stock. This new authorization replaces all previous authorizations. Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions. The Board also dec...
Themefolio
Profiler
Peergroup
© BusinessWire
23.09.2024
ATR
LISTED
NYSE
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, announced that its N-Sorb nitrosamine mitigation solution has been accepted into the U.S. Food & Drug Administration’s (FDA) Emerging Technology Program (ETP), which helps promote the adoption of innovative approaches to p...
Themefolio
Profiler
Peergroup
© BusinessWire
15.08.2024
ATR
LISTED
NYSE
Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
News Preview
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that its Unidose Liquid System (Unidose) is the delivery system approved with neffy® (epinephrine nasal spray), the first and only needle-free treatment approved by the U.S. FDA for the emergency treatment of p...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
